Robert G. Uzzo, MD, Author at Renal and Urology News
Robert G. Uzzo, MD

Robert G. Uzzo, MD

All articles by Robert G. Uzzo, MD

Genetic testing

Cancers, Viruses, and the Evolution of Fear

In The Emperor of All Maladies: A Biographic of Cancer, the oncologist Siddhartha Mukherjee, MD, intuits, “Down to their innate molecular core, cancer cells are hyperactive, survival-endowed, scrappy, fecund, inventive copies of ourselves.”1 Replace “cancer cells” with “viruses” and the quote holds equally true. Darwinian perpetrators of genomic dysregulation, many viruses have integrated foundationally into…

Lymphovascular Invasion Helps Predict Post-RP Biochemical Recurrence

Basic Science: The Tail That Wags the RCC Dog

I recently had reason to survey the progress made in renal cell cancer (RCC) over the last 70 or more years. In 1950, a patient who presented with metastatic RCC had a 0%-5% overall response rate (ORR) to the therapies of the time, with an anticipated overall survival (OS) of approximately 10 months. By 2005,…

Robert G. Uzzo, MD, FACS

The Negative Prostate Biopsy Dilemma

The role of PSA as a cancer screening tool has recently been evaluated by several large high profile studies with varying interpretations of the data. Regardless of where one stands on the debate, among the clinical dilemmas of PSA-based screening is the negative biopsy conundrum where the reality remains that the best one can offer is, “Good news Mr. Smith, I don’t think you have prostate cancer.”

Robert G. Uzzo, MD, FACS

A More Rational Approach To Renal Mass Surgery

In the absence of level I evidence, physician treatment recommendations are subject not only to the objective (interpretations of the cohort literature and practice guidelines) but also the subjective (training patterns, comfort levels, biases and individual experiences).

Robert G. Uzzo, MD, FACS

Who ‘Owns’ Health-Care Cost Decisions?

The imperfections of our nation’s delivery of health care have long been recognized. From poor access for the underinsured and uninsured to potential overutilization by the worried well-insured, the issue has risen to political prominence, with its costs front and center.

Robert G. Uzzo, MD, FACS

Funding Prostate Cancer Prevention Efforts

The risk of a man’s developing prostate cancer is approximately 18%. Whereas it has been estimated that as much as 60% of this risk is due to environmental exposure (J Urol. 2007;178:S9-S13), developing strategies to mitigate this risk is an important public heath concern.

Next post in Commentary